Authors
Latest:
Glenn Wylie, DPhil: The Future of Real-Time NeurofeedbackThe director of the Rocco Ortenzio Neuroimaging Center at Kessler Foundation spoke about the future of functional MRI in providing real-time neurofeedback, and how it might be incorporated as an end point in clinical trials.
Latest:
Erin Conrad, MD: Identifying the Seizure Onset ZoneThe epilepsy fellow at the hospital of the University of Pennsylvania detailed why locating the seizure onset zone plays a crucial role in successful epilepsy surgery.
Latest:
Fred Rincon, MD, MSc : Expanding Stroke Treatment Outside of NeurologyThe chief of cerebrovascular disease at Jefferson University Hospitals explains why teaching stroke protocol and using telemedicine can help close the gaps in stroke care.
Latest:
Targeting the Neonatal Fc Receptor in Myasthenia GravisUnderstanding the pathophysiology of myasthenia gravis is still being determined to this day, but the neonatal Fc receptor is emerging as a potential treatment.
Latest:
The Rationale Behind Recently Approved AXS-07 Combination Therapy for Migraine: Stewart Tepper, MDThe professor of neurology at the Geisel School of Medicine at Dartmouth talked about how the combination therapy involving meloxicam and rizatriptan may provide a more effective approach to treating migraine. [WATCH TIME: 6 minutes]
Latest:
Marie D'hooghe, MD, PhD: Pregnancy Plans for Patients With MSThe neurologist at the National MS Center and University Hospital, in Brussels, discussed the clinician mindset when treating women with MS who plan to get pregnant, and how patients using assistive reproductive treatments should be approached.
Latest:
Elizabeth Thiele, MD, PhD: CBD Shows Low-Dose Efficacy and Safety in TSCThe director of pediatric epilepsy and the Herscot Center for Tuberous Sclerosis Complex at Massachusetts General Hospital, and professor of neurology at Harvard Medical School spoke to the safety outcomes from GWPCARE6 and CBD’s low-dose efficacy.
Latest:
Exploring the Potential Therapeutic Avenue of BTK Inhibitors for Progressive MS: Amit Bar-Or, MD, FRCPC, FAAN, FANAThe Melissa and Paul Anderson President’s Distinguished Professor of Neurology, Perelman School of Medicine, University of Pennsylvania, discussed the promising avenue of BTK inhibitors for addressing progressive multiple sclerosis. [WATCH TIME: 5 minutes]
Latest:
Brian J. Murray, MD: Establishing Normal Values in PolysomnographyThe head of neurology at the Sunnybrook Health Sciences Centre of the University of Toronto spoke about the limited available normative sleep data, and shared insight into the findings of the meta-analysis he and colleagues conducted of more than 150 studies.
Latest:
Progress for Patients With Pediatric MS, Fingolimod's Risk-Benefit Profile: Brenda Banwell, MDThe chief of neurology and codirector of the neuroscience Center at the Children's Hospital of Philadelphia spoke about her presentation at ECTRIMS 2022 on the treatment of pediatric MS. [WATCH TIME: 5 minutes]
Latest:
Thorsten Mikoteit, MD: Sleep Research, an Excellent Source for BiomarkersThe Psychiatrist at Psychiatric Services Solothurn and University of Basel discussed how heart rate variability correlates with sleep stages, which may indicate nocturnal brain activity.
Latest:
Lifestyle Change for Migraine Management: Practical Tips for the Neurologist and PCP, Part 2Trigger avoidance-only strategies don’t actually help migraine patients improve. These are the proactive behaviors that do.
Latest:
Spinal Muscular Atrophy and COVID-19: Guidance and Resources for ProvidersAdvocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.
Latest:
The Challenges of Stroke Care in Rural AmericaStroke care, including acute treatment and prevention, faces unique challenges in rural areas where disease awareness is lacking and access to high-level care in scarce.
Latest:
The Potential of NLRX1 in Immune Regulation and Neuroprotection for Inflammatory Neurodegenerative Disorders: Marjan Gharagozloo, PhDThe assistant professor of neurology at Johns Hopkins Medicine talked about her preclinical research in immunology to explore the intricate mechanisms controlling chronic inflammation in the central nervous system. [WATCH TIME: 5 minutes]
Latest:
Jonathan Voglein, MD: Epilepsy in Alzheimer DiseaseThis data demonstrates that patients with Alzheimer disease are at an increased risk for seizures, in particular in more advanced disease stages, which emphasizes a need for seizure history assessment to inform individual therapeutic decisions and the necessity of systematic treatment studies.
Latest:
Ronald Crystal, MD: The Possibilities of Gene Therapy in Neurodegenerative DiseaseThe chairman of the Department of Genetic Medicine at Weill Cornell Medicine detailed the ongoing research in developing gene therapy for patients with Alzheimer disease.
Latest:
Anna Heidbreder, MD: Anti-IgLON5 Disease, REM Sleep Behavior DisorderHeidbreder further described the current understanding of the condition and what she and her colleagues have found out.
Latest:
Ricardo Osorio, MD: Unanswered Questions About the Relationship Between Sleep, Alzheimer DiseaseThe associate professor at NYU Langone discussed several of the questions that remained unanswered about the relationship between sleep and Alzheimer disease.
Latest:
Neurologic Complications of COVID-19 ReportedThe first presumptive case of acute necrotizing encephalopathy in a patient with confirmed COVID-19 has been published in the journal Radiology.
Latest:
Sanjeev V. Thomas, MD, DM: Managing Epilepsy During PregnancyThe chief of neurology at Sree Chitra Tirunal Institute for Medical Sciences and Technology spoke about how to reassure patients with epilepsy who are planning for pregnancy and how to make treatment decisions with pregnant patients.
Latest:
Bruce Trapp, PhD: Insights Gleaned from Myelocortical Multiple SclerosisThe chairman of the Department of Neuroscience at the Lerner Research Institute spoke about what the implications of the new subtype of MS could be in the understanding of the disease.
Latest:
Rick Wassing, MSc, PhD-C: Restless REM Sleep Contributes to Hyperarousal In InsomniaThose suffering from significant emotional distress and sleep disturbances may benefit from targeted interventions to restore consolidated REM sleep or prevent the occurrence of fragmented REM sleep.
Latest:
World Alzheimer Day 2019: Key Takeaways From Leaders in Alzheimer Disease and DementiaIn recognition of World Alzheimer Day, experts in Alzheimer disease and dementia share insight from the latest Alzheimer Disease International's yearly World Alzheimer Report.
Latest:
ENSEMBLE Study Results, Ocrelizumab as Promising Early Treatment for MS: Robert A. Bermel, MDThe director of the Mellen Center for MS at Cleveland Clinic talked about the ENSEMBLE study results that were presented at the 2023 AAN Annual Meeting. [WATCH TIME: 6 minutes]
Latest:
Lisa Eunyoung Lee, MS, BSc: Myelin Water Imaging in the Spinal CordThe research assistant at the University of British Columbia-Vancouver detailed the success of myelin water imaging in the spinal cords of both healthy controls and patients with multiple sclerosis.
Latest:
Efficacy of Fenfluramine in Reducing Generalized Tonic-Clonic Seizures: Kelly Knupp, MDThe pediatric epileptologist at Children's Hospital Colorado talked about a comprehensive review of various studies assessing fenfluramine in severe seizures associated with developmental and epileptic encephalopathies. [WATCH TIME: 5 minutes]
Latest:
COMT Inhibitors Assist in Control of Parkinson Disease Motor SymptomsMore recently, investigators have discovered that catechol-O-methyltransferase inhibitors can prolong the effects of levodopa, thereby limiting the off-time phenomenon.
Latest:
Lynn Liu, MD: When Should We Measure Antiepileptic Blood Levels?The associate professor of neurology at the University of Rochester shared some of her advice for treating patients with epilepsy and focusing on the patient.
